Global Gaucher Disease Market Insights and Forecast to 2034
Gaucher Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy
Segment by Application
Non-neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease
By Company
Sanofi
Takeda
Actelion Pharma
Pfizer (Protalix)
ISU ABXIS
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Table of Content
1 Study Coverage
1.1 Gaucher Disease Product Introduction
1.2 Market by Type
1.2.1 Global Gaucher Disease Market Size Growth Rate by Type
1.4.2 Enzyme Replacement Therapy
1.4.3 Substrate Reduction Therapy
1.3 Market by Application
1.3.1 Global Gaucher Disease Market Size Growth Rate by Application
1.3.2 Non-neuronopathic Gaucher Disease
1.3.3 Neuronopathic Gaucher Disease
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gaucher Disease Sales Estimates and Forecasts 2016-2027
2.2 Global Gaucher Disease Revenue Estimates and Forecasts 2016-2027
2.3 Global Gaucher Disease Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Gaucher Disease Regions by Sales
2.4.1 Global Top Gaucher Disease Regions by Sales (2016-2021)
2.4.2 Global Top Gaucher Disease Regions by Sales (2022-2027)
2.5 Global Top Gaucher Disease Regions by Revenue
2.5.1 Global Top Gaucher Disease Regions by Revenue (2016-2021)
2.5.2 Global Top Gaucher Disease Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gaucher Disease Sales by Manufacturers
3.1.1 Global Top Gaucher Disease Manufacturers by Sales (2016-2021)
3.1.2 Global Top Gaucher Disease Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Gaucher Disease Sales in 2020
3.2 Global Gaucher Disease Revenue by Manufacturers
3.2.1 Global Top Gaucher Disease Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Gaucher Disease Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Gaucher Disease Revenue in 2020
3.3 Global Gaucher Disease Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gaucher Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gaucher Disease Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gaucher Disease Sales by Type
4.1.1 Global Gaucher Disease Historical Sales by Type (2016-2021)
4.1.2 Global Gaucher Disease Forecasted Sales by Type (2022-2027)
4.1.3 Global Gaucher Disease Sales Market Share by Type (2016-2027)
4.2 Global Gaucher Disease Revenue by Type
4.2.1 Global Gaucher Disease Historical Revenue by Type (2016-2021)
4.2.2 Global Gaucher Disease Forecasted Revenue by Type (2022-2027)
4.2.3 Global Gaucher Disease Revenue Market Share by Type (2016-2027)
4.3 Global Gaucher Disease Price by Type
4.3.1 Global Gaucher Disease Price by Type (2016-2021)
4.3.2 Global Gaucher Disease Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Gaucher Disease Sales by Application
5.1.1 Global Gaucher Disease Historical Sales by Application (2016-2021)
5.1.2 Global Gaucher Disease Forecasted Sales by Application (2022-2027)
5.1.3 Global Gaucher Disease Sales Market Share by Application (2016-2027)
5.2 Global Gaucher Disease Revenue by Application
5.2.1 Global Gaucher Disease Historical Revenue by Application (2016-2021)
5.2.2 Global Gaucher Disease Forecasted Revenue by Application (2022-2027)
5.2.3 Global Gaucher Disease Revenue Market Share by Application (2016-2027)
5.3 Global Gaucher Disease Price by Application
5.3.1 Global Gaucher Disease Price by Application (2016-2021)
5.3.2 Global Gaucher Disease Price Forecast by Application (2022-2027)
6 North America
6.1 North America Gaucher Disease Market Size by Type
6.1.1 North America Gaucher Disease Sales by Type (2016-2027)
6.1.2 North America Gaucher Disease Revenue by Type (2016-2027)
6.2 North America Gaucher Disease Market Size by Application
6.2.1 North America Gaucher Disease Sales by Application (2016-2027)
6.2.2 North America Gaucher Disease Revenue by Application (2016-2027)
6.3 North America Gaucher Disease Market Size by Country
6.3.1 North America Gaucher Disease Sales by Country (2016-2027)
6.3.2 North America Gaucher Disease Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Gaucher Disease Market Size by Type
7.1.1 Europe Gaucher Disease Sales by Type (2017-2027)
7.1.2 Europe Gaucher Disease Revenue by Type (2017-2027)
7.2 Europe Gaucher Disease Market Size by Application
7.2.1 Europe Gaucher Disease Sales by Application (2017-2027)
7.2.2 Europe Gaucher Disease Revenue by Application (2017-2027)
7.3 Europe Gaucher Disease Market Size by Country
7.3.1 Europe Gaucher Disease Sales by Country (2017-2027)
7.3.2 Europe Gaucher Disease Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gaucher Disease Market Size by Type
8.1.1 Asia Pacific Gaucher Disease Sales by Type (2018-2027)
8.1.2 Asia Pacific Gaucher Disease Revenue by Type (2018-2027)
8.2 Asia Pacific Gaucher Disease Market Size by Application
8.2.1 Asia Pacific Gaucher Disease Sales by Application (2018-2027)
8.2.2 Asia Pacific Gaucher Disease Revenue by Application (2018-2027)
8.3 Asia Pacific Gaucher Disease Market Size by Region
8.3.1 Asia Pacific Gaucher Disease Sales by Region (2018-2027)
8.3.2 Asia Pacific Gaucher Disease Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Gaucher Disease Market Size by Type
9.1.1 Latin America Gaucher Disease Sales by Type (2019-2027)
9.1.2 Latin America Gaucher Disease Revenue by Type (2019-2027)
9.2 Latin America Gaucher Disease Market Size by Application
9.2.1 Latin America Gaucher Disease Sales by Application (2019-2027)
9.2.2 Latin America Gaucher Disease Revenue by Application (2019-2027)
9.3 Latin America Gaucher Disease Market Size by Country
9.3.1 Latin America Gaucher Disease Sales by Country (2019-2027)
9.3.2 Latin America Gaucher Disease Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Gaucher Disease Market Size by Type
6.1.1 Middle East and Africa Gaucher Disease Sales by Type (2016-2027)
6.1.2 Middle East and Africa Gaucher Disease Revenue by Type (2016-2027)
6.2 Middle East and Africa Gaucher Disease Market Size by Application
6.2.1 Middle East and Africa Gaucher Disease Sales by Application (2016-2027)
6.2.2 Middle East and Africa Gaucher Disease Revenue by Application (2016-2027)
6.3 Middle East and Africa Gaucher Disease Market Size by Country
6.3.1 Middle East and Africa Gaucher Disease Sales by Country (2016-2027)
6.3.2 Middle East and Africa Gaucher Disease Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Gaucher Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Sanofi Gaucher Disease Product Description
11.1.5 Sanofi Related Developments
11.2 Takeda
11.2.1 Takeda Corporation Information
11.2.2 Takeda Overview
11.2.3 Takeda Gaucher Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Takeda Gaucher Disease Product Description
11.2.5 Takeda Related Developments
11.3 Actelion Pharma
11.3.1 Actelion Pharma Corporation Information
11.3.2 Actelion Pharma Overview
11.3.3 Actelion Pharma Gaucher Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Actelion Pharma Gaucher Disease Product Description
11.3.5 Actelion Pharma Related Developments
11.4 Pfizer (Protalix)
11.4.1 Pfizer (Protalix) Corporation Information
11.4.2 Pfizer (Protalix) Overview
11.4.3 Pfizer (Protalix) Gaucher Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer (Protalix) Gaucher Disease Product Description
11.4.5 Pfizer (Protalix) Related Developments
11.5 ISU ABXIS
11.5.1 ISU ABXIS Corporation Information
11.5.2 ISU ABXIS Overview
11.5.3 ISU ABXIS Gaucher Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 ISU ABXIS Gaucher Disease Product Description
11.5.5 ISU ABXIS Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Gaucher Disease Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Sanofi Gaucher Disease Product Description
11.1.5 Sanofi Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Gaucher Disease Value Chain Analysis
12.2 Gaucher Disease Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gaucher Disease Production Mode & Process
12.4 Gaucher Disease Sales and Marketing
12.4.1 Gaucher Disease Sales Channels
12.4.2 Gaucher Disease Distributors
12.5 Gaucher Disease Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gaucher Disease Industry Trends
13.2 Gaucher Disease Market Drivers
13.3 Gaucher Disease Market Challenges
13.4 Gaucher Disease Market Restraints
14 Key Findings in The Global Gaucher Disease Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer